After a national search, David Oupicky, Ph.D., has been named chair of the UAB Department of Biomedical Engineering, a joint department of the UAB Heersink School of Medicine and the UAB School of Engineering. His appointment is effective April 1, 2027.
Oupicky joins UAB from the University of Nebraska Medical Center (UNMC), where he serves as professor and Parke-Davis Chair in Pharmaceutics in the Department of Pharmaceutical Sciences. He also directs the Center for Drug Delivery and Nanomedicine, an interdisciplinary research center that bridges medicine, engineering, pharmaceutical sciences, cancer research, and related biomedical fields.
“What drew me to UAB was the ambitious vision we share for biomedical engineering and the strong commitment from both schools to making it a reality,” Oupicky said. “I look forward to working with the faculty, students, and colleagues across UAB to build on the department’s strengths, recruit outstanding new faculty, and expand our research and educational programs.”
An internationally recognized leader in drug delivery, nanomedicine, and RNA therapeutics, Oupicky has built a distinguished research program focused on developing advanced therapeutic delivery systems for cancer, fibrosis, inflammatory diseases, and genetic disorders. His work integrates polymer engineering, nucleic acid delivery, cancer nanomedicine, inhalation therapies, formulation science, and translational technology development, resulting in sustained National Institutes of Health (NIH) funding, approximately 200 publications, and more than 13,000 citations.
Oupicky has a demonstrated commitment to interdisciplinary collaboration and scientific mentorship. He previously directed UNMC’s largest Ph.D. program, served as director and principal investigator of the NIH-funded P30 Center of Biomedical Research Excellence (COBRE) focused on nanomedicine, and has mentored more than 100 trainees.
“Dr. Oupicky is an accomplished scientist, innovator, educator, and academic leader whose career reflects the collaborative spirit that defines biomedical engineering,” said Anupam Agarwal, M.D., senior vice president for medicine and dean of the Heersink School of Medicine. “His extensive experience building interdisciplinary research programs, developing future scientific leaders, and advancing translational discoveries will position the department for continued growth and impact.”
Among his many honors, Oupicky is a fellow of the Controlled Release Society and the National Strategic Research Institute. He was also selected for the Fulbright Specialist Roster for 2026-2029.
Oupicky earned his Ph.D. in macromolecular chemistry from the Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic in Prague and completed postdoctoral training in gene delivery and therapy at the University of Birmingham in the United Kingdom. He also holds a master's degree in polymer engineering from the University of Chemistry and Technology, Prague.
“With a distinguished record of research excellence and academic leadership, Dr. Oupicky has consistently advanced innovation through interdisciplinary partnerships,” said Jeffrey Holmes, M.D., Ph.D., dean of the UAB School of Engineering. “His expertise at the intersection of engineering, medicine, and therapeutics aligns perfectly with the mission of our joint department, and I am confident his leadership will further elevate UAB’s reputation as a destination for innovation, discovery, and translational impact.”